Speech-Language Pathologists in Hastings, MN Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Stephanie Flom Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 11th St W, Hastings, MN 55033 Phone: 651-480-7000 |
Shannon Marie Siepelmeyer, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1312 S Frontage Rd, Hastings, MN 55033 Phone: 651-455-0561 Fax: 651-457-4401 |
News Archive
At Senate hearing, Democrats blast 'mini-med' insurance policies
The New York Times: "More than a million Americans enrolled in [limited benefit, or mini med,] plans think they have health insurance to protect them from financial catastrophe if they become seriously ill or hurt, [Senator John D.] Rockefeller said. 'In fact, they don't,' he said. 'It's worse than nothing because of the false expectations and the false hope,' Mr. Rockefeller said" at the Senate hearing.
Redistricting - not just for politics - now being considered for liver transplant waiting list system
Where you live can affect your chances of getting a liver transplant, and your risk of dying while waiting. The nation's transplant network says it's time to make the system fairer -; and it may take a cue from how politicians redraw voting maps.
World Health Assembly endorses Global Vaccine Action Plan
Ministers of Health from 194 countries at the Sixty-fifth World Health Assembly today endorsed a landmark Global Vaccine Action Plan (GVAP), a roadmap to prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
Health IT legislation stalled by privacy concerns
Legislation that would promote the adoption and standardization of health information technology is "knotted up" in Congress over privacy issues, CQ Today reports (Wayne, CQ Today, 6/2).
New Drug Application for NicOx's naproxcinod accepted for filing
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
› Verified 3 days ago
Chiropractors
Physical Therapists
Optometrists
Occupational Therapists
Audiologists
Podiatrists
Speech-Language Pathologists